Compare companies
| Cresco Labs Inc. | Roche Holding | Abcam plc | ||||
|---|---|---|---|---|---|---|
| Capitalization | ||||||
| Price | 0.64 | 43.38 | 22.25 | |||
| Price priv. | ||||||
| Number of shares, million | 339.71 | 797.24 | 303.77 | |||
| Capitalization, billion | 0.3555 | 234.03 | 4.77 | |||
| EBITDA, billion | -0.0107 | 20.86 | 0.0561 | |||
| EV, billion | 0.8699 | 48.09 | 5.43 | |||
| Profit and loss report | ||||||
| Net profit, billion | -0.1755 | 11.5 | -0.0112 | |||
| Revenue, billion | 0.7709 | 60.44 | 0.475 | |||
| EPS | -0.5167 | 14.42 | -0.0483 | |||
| Balance | ||||||
| Assets, billion | 1.36 | 90.47 | 1.39 | |||
| Debt, billion | 0.6663 | 29.21 | 0.2941 | |||
| Balance cost, billion | 0.5057 | 29.32 | 0.9547 | |||
| Cash, billion | 0.1034 | 5.38 | 0.1169 | |||
| Coefficients | ||||||
| Dividend yield, % | 0 | 0 | 0 | |||
| Dividend | 0 | 0 | 0 | |||
| Dividend yield priv., % | 0 | 0 | 0 | |||
| Dividend priv. | 0 | 0 | 0 | |||
| Dividends/profit, % | 0 | 66.01 | 202.17 | |||
| P/S | 0.6169 | 0.4014 | 11.06 | |||
| P/BV | 1.11 | 0.7293 | 5.51 | |||
| P/E | 0 | 2.11 | 778.7 | |||
| Ev/Ebitda | -86.35 | 2.49 | 96.88 | |||
| Debt/Ebitda | -62.27 | 1.4 | 5.24 | |||
| Efficiency | ||||||
| ROE | -34.71 | 39.22 | -1.34 | |||
| ROA | -12.92 | 12.71 | -0.9103 | |||
| ROIC | -24.44 | 26.27 | 0.68 | |||
| Ebitda margin | -1.39 | 34.51 | 11.81 | |||
| Net margin | -22.77 | 19.02 | -2.35 | |||
| Momentum | ||||||
| 1 week, price changes | -10.49 % | +0.0461 % | 0 % | |||
| 1 month, price changes | -27.68 % | +4.5 % | 0 % | |||
| 3 months, price changes | -24.71 % | +24.08 % | 0 % | |||
| 6 months, price changes | -61.21 % | +8.07 % | 0 % | |||
| 1 year, price changes | -71.3 % | +38.55 % | 0 % | |||
| 3 years, price changes | -89.1 % | -18.52 % | +24.13 % | |||
| 5 years, price changes | -78.74 % | +16.69 % | +45.42 % | |||
| 10 years, price changes | ||||||
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
